Can a drug that depletes b cells help fight prostate cancer?
NCT ID NCT01804712
First seen Mar 25, 2026 · Last updated May 20, 2026 · Updated 10 times
Summary
This early-phase pilot study tested whether giving rituximab (a drug that removes B cells) before prostate removal surgery could reduce B cell levels in the tumor. Eight men with high-risk prostate cancer participated. The main goal was to see if the drug changes the tumor's immune environment, not to cure the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Moores UCSD Cancer Center
La Jolla, California, 92093-0698, United States
Conditions
Explore the condition pages connected to this study.